Your browser doesn't support javascript.
loading
Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib.
He, Cong; Jaffar Ali, Doulathunnisa; Xu, Huantian; Kumaravel, Subhashree; Si, Ke; Li, Yumin; Sun, Bo; Ma, Junqing; Xiao, Zhongdang.
Afiliación
  • He C; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
  • Jaffar Ali D; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China; Key Laboratory for Developmental Genes and Human Disease, Ministry of Education, Institute of Life Sciences, Jiangsu Province High-Tech Key Laboratory
  • Xu H; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
  • Kumaravel S; Department of Medical Physiology, College of Medicine, Texas A & M Health Science Center, College Station, TX, 77843, USA.
  • Si K; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
  • Li Y; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
  • Sun B; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
  • Ma J; Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
  • Xiao Z; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China. Electronic address: zdxiao@seu.edu.cn.
Exp Cell Res ; 392(2): 112040, 2020 07 15.
Article en En | MEDLINE | ID: mdl-32380039

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas Activadoras de ras GTPasa / Células Epiteliales / Micropartículas Derivadas de Células / Sistemas CRISPR-Cas / Sorafenib / Neoplasias Hepáticas Límite: Animals / Female / Humans Idioma: En Revista: Exp Cell Res Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas Activadoras de ras GTPasa / Células Epiteliales / Micropartículas Derivadas de Células / Sistemas CRISPR-Cas / Sorafenib / Neoplasias Hepáticas Límite: Animals / Female / Humans Idioma: En Revista: Exp Cell Res Año: 2020 Tipo del documento: Article País de afiliación: China